A groundbreaking phase 2 trial explores a novel, chemotherapy-free immunotherapy for relapsed indolent B-cell lymphomas, aiming to enhance patient outcomes.

Diffuse large B-cell lymphoma (DLBCL) is an aggressive and rapidly progressing form of lymph node cancer that affects around 6,000 people in Germany ...

First Phase 2 chemotherapy-free, lymphodepletion-free, off-the-shelf CAR-NK cell therapy plus ANKTIVA® and rituximab regimen ...

Blackberries provide vitamin C, fiber, and anthocyanins that have benefits for digestive and heart health. Their antioxidants protect against cell damage.

Adequate and healthy nutrition is important during the postpartum time to support wound healing, hormone balance, energy, ...

HONG KONG SAR - Media OutReach Newswire - 3 February 2026 - Liver cancer is one of the three deadliest cancers worldwide, and ...

Health News Our heart, a vital organ, functions tirelessly from birth until death. It beats approximately 1,15,000 times a ...

The COVID-19 pandemic gave us tremendous perspective on how wildly symptoms and outcomes can vary between patients ...

Scientists have uncovered a direct molecular mechanism by which gut bacteria inject proteins into human cells, reshaping immune responses and potentially driving inflammatory disease. Scientists have ...

A 52-year-old woman experiences chronic GvHD post-stem cell transplant, showcasing complex symptoms and treatment challenges. Discover her journey and management strategies. Dr. Shune discusses how ...

The FDA Center for Drug Evaluation and Research has accepted a letter of intent for the first biomarker for idiopathic pulmonary fibrosis into its Biomarker Qualification Program, according to a press ...

Targeted therapies have been moved forward in the treatment of both pemphigus and pemphigoid diseases, a factor behind an urgency for rapid diagnosis.